News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
White Marvin L
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/30/2023 |
4
| White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns:
| Granted 33,847 shares
@ $0 |
|
03/07/2023 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Exercised 9,582 restricted stock units
@ $0 Granted 38,750 restricted stock units
@ $0 Granted 38,750 options to buy
@ $2.15, valued at
$83.3k
|
|
01/30/2023 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Exercised 4,791 restricted stock units
@ $0 |
|
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/29/2020 |
4
| White Marvin L (CEO and President) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Disposed/sold 2,545 options to buy
@ $0 Disposed/sold 14,319 options to buy
@ $0 Disposed/sold 5,414 options to buy
@ $0 Disposed/sold 10,828 options to buy
@ $0 Granted 16,625 options to buy
@ $8.56, valued at
$142.3k
Granted 4,813 options to buy
@ $8.56, valued at
$41.2k
|
|
03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/14/2019 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Bought 50,000 shares
@ $0.88, valued at
$44k
|
|
05/20/2019 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Bought 30,000 shares
@ $0.81, valued at
$24.3k
|
|
05/14/2019 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Bought 10,000 shares
@ $0.78, valued at
$7.8k
|
|
03/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/06/2018 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Bought 10,000 shares
@ $2.38, valued at
$23.8k
|
|
05/23/2018 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Paid exercise price by delivering 8,373 shares
@ $5.61, valued at
$47k
Exercised 35,644 options to buy
@ $0 |
|
03/21/2018 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Sold 100,000 shares
@ $2.93, valued at
$293k
|
|
03/13/2018 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Granted 151,600 options to buy
@ $3.13, valued at
$474.5k
|
|
06/01/2017 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Granted 75,800 options to buy
@ $2.15, valued at
$163k
|
|
05/23/2017 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns:
| Exercised 35,643 restricted stock units
@ $0 Exercised 17,828 restricted stock units
@ $0 |
|
03/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/27/2017 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc. |
01/04/2017 |
4
| White Marvin L (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns:
| Granted 453 options to buy
@ $36.2, valued at
$16.4k
|
|
08/05/2016 |
4
| White Marvin L (President and CEO) has filed a Form 4 on Aptevo Therapeutics Inc. |
07/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/19/2016 |
4
| White Marvin L (Director) has filed a Form 4 on WP Glimcher Inc. |
05/12/2016 |
4
| White Marvin L (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns:
| Granted 8,897 options to buy
@ $6.24, valued at
$55.5k
|
|
03/09/2016 |
4
| White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns:
| Sold 10,800 shares
@ $35.42, valued at
$382.5k
Sold 7,200 shares
@ $35.42, valued at
$255k
Sold 4,800 shares
@ $35.42, valued at
$170k
Sold 3,134 shares
@ $35.42, valued at
$111k
Exercised 10,800 options to buy
@ $15.75, valued at
$170.1k
Exercised 7,200 options to buy
@ $22.02, valued at
$158.5k
Exercised 7,200 options to buy
@ $14.66, valued at
$105.6k
Exercised 4,800 options to buy
@ $14.25, valued at
$68.4k
Exercised 3,134 options to buy
@ $20.44, valued at
$64.1k
|
|
05/21/2012 |
4
| White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns:
| Granted 3,600 shares
@ $0 Granted 7,200 options to buy
@ $14.66, valued at
$105.6k
|
|
05/23/2011 |
4
| White Marvin L (Director) has filed a Form 4 on Emergent BioSolutions Inc.
Txns:
| Granted 3,600 shares
@ $0 Granted 7,200 options to buy
@ $22.02, valued at
$158.5k
|
|
|
|
|